Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings (original) (raw)
A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)
James Swanson
PEDIATRICS, 2004
View PDFchevron_right
Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet ® Retard and Concerta ® —a Randomized, Controlled, Double-Blind Multic...
Claudia Ose
Journal of Child and Adolescent Psychopharmacology, 2011
View PDFchevron_right
Comparative Efficacy of Two Once Daily Methylphenidate Formulations (Ritalin?? LA???1 and Concerta??) and Placebo in Children with Attention Deficit Hyperactivity Disorder Across the School Day
Frank Lopez
Pediatric Drugs, 2003
View PDFchevron_right
Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder
Marc Atkins
2000
View PDFchevron_right
Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers With ADHD
James McCracken, B. Vitiello, Howard Abikoff
Journal of the American Academy of Child & Adolescent Psychiatry, 2006
View PDFchevron_right
A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder
Tia Sternat
CNS drugs, 2014
View PDFchevron_right
Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA
John March
Journal of The American Academy of Child and Adolescent Psychiatry, 2001
View PDFchevron_right
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD
Graeme Donnelly
Journal of Attention Disorders, 2021
View PDFchevron_right
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants
Richard Weisler
European Child & Adolescent Psychiatry, 2010
View PDFchevron_right
Switching from methylphenidate immediate release to MPH-SODAS™ in attention-deficit/hyperactivity disorder
Henrique Ludwig
European Child & Adolescent Psychiatry, 2008
View PDFchevron_right
A Double-Blind, Placebo-Controlled Study of Modified-Release Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
James Swanson
PEDIATRICS, 2002
View PDFchevron_right
A Parent Guide To Understanding the Effects of Ritalin (Methylphenidate Hydrochloride)
Orlando Villegas
1992
View PDFchevron_right
A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder
Margaret D Weiss
The Canadian Journal of Clinical Pharmacology Journal Canadien De Pharmacologie Clinique, 2006
View PDFchevron_right
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
Alessandro Zuddas
BMC Psychiatry, 2013
View PDFchevron_right
Effectiveness of Methylphenidate in the 10-Month Continuation Phase of the Preschoolers with ADHD Treatment Study (PATS)
B. Vitiello, Howard Abikoff, Howard Abikoff
Journal of Child and Adolescent Psychopharmacology, 2007
View PDFchevron_right
Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study
Graeme Donnelly
Journal of Child and Adolescent Psychopharmacology
View PDFchevron_right
Safety and Tolerability of Methylphenidate in Preschool Children With ADHD
James McCracken, B. Vitiello, Howard Abikoff
Journal of the American Academy of Child & Adolescent Psychiatry, 2006
View PDFchevron_right
Switching from immediate- to sustained-release psychostimulants in routine treatment of children with attention-deficit hyperactivity disorder
saeed nazir
Psychiatric Bulletin, 2006
View PDFchevron_right
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
Tin Hung Wong
View PDFchevron_right
Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders
Michael Aman
Journal of Child and Adolescent Psychopharmacology, 2009
View PDFchevron_right
Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
John Orazem
Journal of Child and Adolescent Psychopharmacology
View PDFchevron_right
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
vinod kumar
Advances in Therapy, 2014
View PDFchevron_right
Rationale, Design, and Methods of the Preschool ADHD Treatment Study (PATS)
Timothy Wigal
Journal of the American Academy of Child & Adolescent Psychiatry, 2006
View PDFchevron_right
Methylphenidate delivery mechanisms for the treatment of children with attention deficit hyperactivity disorder: Heterogeneity in parent preferences
Sarah Dewilde, PhD
International Journal of Technology Assessment in Health Care, 2011
View PDFchevron_right
Pharmacokinetics of Methylphenidate In Preschoolers With Attention-Deficit/Hyperactivity Disorder
Jonathan Martinez
Journal of Child and …, 2007
View PDFchevron_right